PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25411359-8	2015	Interleukin-6 treatment and overexpression of STAT3 enhanced anoikis resistance and protected the cells from PL-induced anoikis.	piplartine	109-111	interleukin 6	Mus musculus	0-13	
25216522-7	2014	Over-expression of STAT3 or treatment with IL-6 not only increased anoikis resistance, but also protected the cancer cells from PL-induced anoikis.	piplartine	128-130	interleukin 6	Mus musculus	43-47	
34207356-3	2021	The results demonstrated that piplartine suppresses iNOS and COX-2 expression, reduces PGE2, TNF-alpha and IL-6 production, decreases the phosphorylation of MAPKs and NF-kappaB and attenuates NF-kappaB activity by LPS-activated macrophages.	piplartine	30-40	interleukin 6	Mus musculus	107-111	
34207356-5	2021	Moreover, piplartine reduces the production of nitric oxide (NO) and TNF-alpha, IL-6 and IL-1beta, decreases LPS-induced tissue damage, attenuates infiltration of inflammatory cells and enhances the survival rate.	piplartine	10-20	interleukin 6	Mus musculus	80-84